SavedAdd your journal

Journals / Turkish Journal of Hematology / 2013 / Cilt: 30 - Sayı: 2

Miyeloablatif olmayan allojeneik kök hücre nakli sonrası derin ven trombozu: Üç vaka sunumu ve literatürün gözden geçirilmesi

Deep vein thrombosis following non-myeloablative allogeneic stem cell transplantation: Presentation of three cases and literature review

Evren ÖZDEMİR
Emin KANSU
Pages
188–190
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein we present 3 cases of DVT following NMA allo-SCT and a literature review.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The incidence of deep vein thrombosis (DVT) after non-myeloablative (NMA) allogeneic stem cell transplantation (allo-SCT) is unknown.
📊
Key Findings & Data:The incidence of DVT among patients that underwent NMA allo-SCT at our hospital was 4.1% (3 of 73) over the course of last 8 years, and to the best of our knowledge this is the first study to report the incidence of DVT following NMA allo-SCT.
💡
Conclusion & Impact:Herein we present 3 cases of DVT following NMA allo-SCT and a literature review.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The incidence of deep vein thrombosis (DVT) after non-myeloablative (NMA) allogeneic stem cell transplantation (allo-SCT) is unknown. In addition, very few studies on the predisposing factors for DVT post SCT have been published. The incidence of DVT among patients that underwent NMA allo-SCT at our hospital was 4.1% (3 of 73) over the course of last 8 years, and to the best of our knowledge this is the first study to report the incidence of DVT following NMA allo-SCT. The present findings show that NMA allo-SCT patients may have multiple risk factors for DVT. Herein we present 3 cases of DVT following NMA allo-SCT and a literature review.

Özet

Miyeloablatif olmayan allojeneik kök hücre nakli (NST) sonrası derin ven trombozu (DVT) sıklığı bilinmemektedir. Ek olarak, allojeneik nakil sonrası DVT gelişiminin nedenleri ile ilgili çok az sayıda çalışma mevcut olup, bu çalışmalarda izole bazı etiyolojik faktörler tanımlanmıştır. Merkezimizde NST protokolleri ile tedavi edilen hastalarda DVT gelişme sıklığı son sekiz yıl içinde %4,1 (73 hastada 3 vaka) olarak bulunmuş olup, bu hasta grubunda bildirilen ilk rapordur. NST sonrası DVT gelişimi ile ilgili gözlemimiz, bu hastalarda birden çok risk faktörünün bir arada bulunduğudur. Burada, bu hasta grubunda DVT gelişen üç vaka sunulmuş ve ilgili literatür gözden geçirilmiştir.

🔖

Cite This Article

ÖZDEMİR, E., KANSU, E. (2013). Miyeloablatif olmayan allojeneik kök hücre nakli sonrası derin ven trombozu: Üç vaka sunumu ve literatürün gözden geçirilmesi. Turkish Journal of Hematology, Cilt: 30 - Sayı: 2, 188–190. https://ajindex.com/articles/412599

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Pihusch R, Salat C, Schmidt E, Göhring P, Pihusch M, Hiller E, Holler E, Kolb HJ. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 2002;74:1303-1309
  2. Gordon BG, Saving KL, McCallister JA, Warkentin PI, McConnell JR, Roberts WM, Coccia PF Haire WD. Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation. Bone Marrow Transplant 1991;8:323-325
  3. Grigg A, Gibson R, Bardy P, Szer J. Acute portal vein thrombosis after autologous stem cell transplantation. Bone Marrow Transplant 1996;18:949-953
  4. Gordon BG, Haire WD, Patton DF Manno PJ, Reed EC. Thrombotic complications of BMT: association with protein C deficiency. Bone Marrow Transplant 1993;11:61-65
  5. Gordon B, Haire W, Kessinger A, Duggan M, Armitage J. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 1991;8:497-502
  6. Kasamon KM, Drachenberg CI, Rapoport AP, Badros A. Catastrophic antiphospholipid syndrome: atypical presentation in the setting of chronic graft versus host disease: case report and review of the literature. Haematologica 2005;90:17
  7. Gonsalves A, Carrier M, Wells PS, McDiarmid SA, Huebsch LB, Allan DS. Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation. J Thromb Haemost 2008;6:1468-73
  8. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995;85:1504-1507
  9. Fijnheer R, Paijmans B, Verdonck LF Nieuwenhuis HK, Roest M, Dekker AW. Factor V Leiden in central venous catheter- associated thrombosis. Br J Haematol 2002;118:267-270
  10. Jansen FH, van der Straaten HM, Roest M, Haas F de Groot PG, Fijnheer R. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis. Haematologica 2005;90:499-504.